| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ -30.46K | $ 337.64K | $ 404.76K | $ 49.17K |
| Gross Profit | $ -1.57K | $ -882.90K | $ -348.17K | $ -195.13K | $ -261.91K |
| Operating Income | $ -749.74K | $ -2.46M | $ -4.60M | $ -8.56M | $ -9.38M |
| EBITDA | $ -748.17K | $ -2.09M | $ -4.10M | $ -8.22M | $ -9.13M |
| Net Income | $ -2.98M | $ -2.32M | $ -4.47M | $ -8.59M | $ -9.49M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 473.88K | $ 22.23K | $ 136.55K | $ 412.01K | $ 2.84M |
| Total Assets | $ 589.06K | $ 190.19K | $ 1.17M | $ 2.25M | $ 5.79M |
| Total Debt | $ 0.00 | $ 0.00 | $ 429.32K | $ 672.38K | $ 1.03M |
| Net Debt | $ -473.88K | $ -22.23K | $ 292.77K | $ 260.37K | $ -1.81M |
| Total Liabilities | $ 329.83K | $ 1.69M | $ 2.68M | $ 1.53M | $ 2.04M |
| Stockholders' Equity | $ 259.22K | $ -1.81M | $ -1.51M | $ 726.60K | $ 3.75M |
| Cash Flow | |||||
| Free Cash Flow | $ -138.71K | $ -1.48M | $ -2.30M | $ -5.19M | $ -5.69M |
| Operating Cash Flow | $ -138.71K | $ -1.48M | $ -2.30M | $ -5.16M | $ -5.15M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -1.38K | $ -27.25K | $ -621.20K |
| Financing Cash Flow | $ 536.34K | $ 1.37M | $ 1.97M | $ 3.03M | $ 6.23M |
Psyrx Bio-Tech Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.